» Articles » PMID: 34095014

Phosphorylation in Novel Mitochondrial Creatine Kinase Tyrosine Residues Render Cardioprotection Against Hypoxia/Reoxygenation Injury

Overview
Date 2021 Jun 7
PMID 34095014
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Ischemic cardiomyopathy (ICM) is the leading cause of heart failure. Proteomic and genomic studies have demonstrated ischemic preconditioning (IPC) can assert cardioprotection against ICM through mitochondrial function regulation. Considering IPC is conducted in a relatively brief period, regulation of protein expression also occurs very rapidly, highlighting the importance of protein function modulation by post-translational modifications. This study aimed to identify and analyze novel phosphorylated mitochondrial proteins that can be harnessed for therapeutic strategies for preventing ischemia/reperfusion (I/R) injury.

Methods: Sprague-Dawley rat hearts were used in an Langendorff system to simulate normal perfusion, I/R, and IPC condition, after which the samples were prepared for phosphoproteomic analysis. Employing human cardiomyocyte AC16 cells, we investigated the cardioprotective role of CKMT2 through overexpression and how site-directed mutagenesis of putative CKMT2 phosphorylation sites (Y159A, Y255A, and Y368A) can affect cardioprotection by measuring CKMT2 protein activity, mitochondrial function and protein expression changes.

Results: The phosphoproteomic analysis revealed dephosphorylation of mitochondrial creatine kinase (CKMT2) during ischemia and I/R, while preserving its phosphorylated state during IPC. CKMT2 overexpression conferred cardioprotection against hypoxia/reoxygenation (H/R) by increasing cell viability and mitochondrial adenosine triphosphate level, preserving mitochondrial membrane potential, and reduced reactive oxygen species (ROS) generation, while phosphomutations, especially in Y368, nullified cardioprotection by significantly reducing cell viability and increasing ROS production during H/R. CKMT2 overexpression increased mitochondrial function by mediating the proliferator-activated receptor γ coactivator-1α/estrogen-related receptor-α pathway, and these effects were mostly inhibited by Y368A mutation.

Conclusion: These results suggest that regulation of quantitative expression and phosphorylation site Y368 of CKMT2 offers a unique mechanism in future ICM therapeutics.

Citing Articles

Creatine kinase mitochondrial 2 promotes the growth and progression of colorectal cancer enhancing Warburg effect through lactate dehydrogenase B.

Cai S, Xia Q, Duan D, Fu J, Wu Z, Yang Z PeerJ. 2024; 12:e17672.

PMID: 38952967 PMC: 11216189. DOI: 10.7717/peerj.17672.


Maintaining energy provision in the heart: the creatine kinase system in ischaemia-reperfusion injury and chronic heart failure.

Lygate C Clin Sci (Lond). 2024; 138(8):491-514.

PMID: 38639724 PMC: 11040329. DOI: 10.1042/CS20230616.


Cytosolic nucleic acid sensing and mitochondrial transcriptomic changes as early triggers of metabolic disease in db/db mice.

Ludwig-Slomczynska A, Seweryn M, Wiater J, Borys A, Ledwon A, Druszczynska M Mamm Genome. 2023; 35(1):68-76.

PMID: 37979047 PMC: 10884043. DOI: 10.1007/s00335-023-10026-z.


Proteomics as a Tool for the Study of Mitochondrial Proteome, Its Dysfunctionality and Pathological Consequences in Cardiovascular Diseases.

Stastna M Int J Mol Sci. 2023; 24(5).

PMID: 36902123 PMC: 10003354. DOI: 10.3390/ijms24054692.


Proteomics Revealed That Mitochondrial Function Contributed to the Protective Effect of Herba Siegesbeckiae Against Cardiac Ischemia/Reperfusion Injury.

Wei X, Wu Y, Pan H, Zhang Q, He K, Xia G Front Cardiovasc Med. 2022; 9:895797.

PMID: 35872903 PMC: 9299383. DOI: 10.3389/fcvm.2022.895797.


References
1.
Brown D, Perry J, Allen M, Sabbah H, Stauffer B, Shaikh S . Expert consensus document: Mitochondrial function as a therapeutic target in heart failure. Nat Rev Cardiol. 2016; 14(4):238-250. PMC: 5350035. DOI: 10.1038/nrcardio.2016.203. View

2.
Huang D, Sherman B, Lempicki R . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1):44-57. DOI: 10.1038/nprot.2008.211. View

3.
Kim H, Thu V, Heo H, Kim N, Han J . Cardiac proteomic responses to ischemia-reperfusion injury and ischemic preconditioning. Expert Rev Proteomics. 2011; 8(2):241-61. DOI: 10.1586/epr.11.8. View

4.
Nabeebaccus A, Zheng S, Shah A . Heart failure-potential new targets for therapy. Br Med Bull. 2016; 119(1):99-110. PMC: 5862241. DOI: 10.1093/bmb/ldw025. View

5.
Buja L . The pathobiology of acute coronary syndromes: clinical implications and central role of the mitochondria. Tex Heart Inst J. 2013; 40(3):221-8. PMC: 3709209. View